Securing the best price for an out-licensed asset

Biotech Ensysce, whose mission is to stem the prescription drug abuse crisis, seeks out-licensing or partnering opportunities around the world for its proprietary abuse and overdose resistant prodrug technologies. The company turned to Cortellis Deals Intelligence™ because, when used in combination with Cortellis Competitive Intelligence™, it offers all the data the company needs — deals, drug, company and patent information — in one platform.